OPKO Health, Inc. (NASDAQ:OPK) Q1 2025 Earnings Call Transcript
Operator: Good afternoon, and welcome to the OPKO Health First Quarter 2025 Financial Results Conference Call. All participants will be in a listen-only mode.
Opko Health Inc. (OPK)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Rubric Capital Management David Rosen | 48,706,640 | $71,598,761 | 0.91% | |
| 2. | Millennium Management Israel Englander | 4,588,526 | $6,745,133 | +86% | 0% |
| 3. | Citadel Investment Group Ken Griffin | 3,210,290 | $4,719,127 | +29% | 0% |
| 4. | 1,577,900 | $2,319,513 | -27% | 0.03% | |
| 5. | 1,401,700 | $2,060,499 | +21% | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $1.36 | 125,000 | 214,001,448 | 2025-04-10 | Filing | ||
| $1.48 | 125,000 | 213,876,448 | 2025-04-08 | Filing | ||
| $1.65 | 100,000 | 213,751,448 | 2025-04-01 | Filing | ||
| $1.70 | 150,000 | 213,651,448 | 2025-03-28 | Filing | ||
| $1.74 | 200,000 | 213,501,448 | 2025-03-17 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $8.07 | 112,975 | Officer | 161,293 | 2017-03-14 | Filing | |
| $9.85 | 3,000 | Director | 284,088 | 2016-05-13 | Filing | |
| $9.84 | 5,616 | Director | 287,088 | 2016-05-13 | Filing | |
| $9.84 | 900 | Director | 292,704 | 2016-05-13 | Filing | |
| $9.83 | 4,000 | Director | 293,604 | 2016-05-13 | Filing |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 29,500,071 | $48,970,118 | 0% | |
| 2. | 27,604,974 | $45,824,256 | 0% | |
| 3. | 4,001,214 | $6,642,016 | 0% | |
| 4. | 2,741,986 | $4,551,697 | 0% | |
| 5. | 1,217,360 | $2,020,818 | 0.13% |
News See All
10 Best Stocks Under $3 to Buy Now
Investors are grappling with Trump-fueled stock market volatility in 2025.
OPKO Health, Inc. (NASDAQ:OPK) Q4 2024 Earnings Call Transcript
Operator: Good day. And welcome to the OPKO Health Fourth Quarter 2024 Financial Results Conference Call. All participants will be in a listen-only mode.
10 Best Nasdaq Stocks Under $5 to Buy
The Nasdaq is one of the top three most-followed stock market indices in the United States, comprising over 2,500 stocks.
12 Stocks Under $5 With Biggest Upside Potential
On January 20, Bloomberg reported that relief swept through the markets as it became clear that Donald Trump would not immediately impose China-specific tariffs on his first day in office, sparking a ...
11 Best NASDAQ Penny Stocks To Buy Right Now
The NASDAQ Stock Market is home to some of the world's largest companies in the world and also hosts several hundred penny stocks.
OPKO Health, Inc. (NASDAQ:OPK) Q3 2024 Earnings Call Transcript
Operator: Good day, and welcome to the OPKO Health Third Quarter of 2024 Financial Results Conference Call. All participants will be in listen-only mode.
OPKO Health, Inc. (NASDAQ:OPK) Q2 2024 Earnings Call Transcript
Operator: Good day, and welcome to the OPKO Health Second Quarter 2024 Financial Results Conference Call. All participants will be in listen-only mode.
10 Most Shorted Stocks That Are Loved by Analysts
Short selling is one of the more controversial ways of making money on the stock market.
5 Penny Stocks with Insider Buying in 2024
Biotech company 2Seventy Bio Inc (NASDAQ:TSVT) saw heavy insider buying activity earlier this year when Casdin Capital, LLC, which has a director status at 2Seventy Bio Inc (NASDAQ:TSVT), bought 777...
Billionaire Hedge Funds
